001     859436
005     20210130000255.0
024 7 _ |a 10.1039/C8RA09067J
|2 doi
024 7 _ |a 2128/21189
|2 Handle
024 7 _ |a WOS:000457292800036
|2 WOS
037 _ _ |a FZJ-2019-00292
082 _ _ |a 540
100 1 _ |a Moussa, Mariam
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Co-culture of the fungus Fusarium tricinctum with Streptomyces lividans induces production of cryptic naphthoquinone dimers
260 _ _ |a London
|c 2019
|b RSC Publishing
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1547561302_11586
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Co-cultivation of the endophytic fungus Fusarium tricinctum with Streptomyces lividans on solid rice medium led to the production of four new naphthoquinone dimers, fusatricinones A–D (1–4), and a new lateropyrone derivative, dihydrolateropyrone (5), that were not detected in axenic fungal controls. In addition, four known cryptic compounds, zearalenone (7), (−)-citreoisocoumarin (8), macrocarpon C (9) and 7-hydroxy-2-(2-hydroxypropyl)-5-methylchromone (10), that were likewise undetectable in extracts from fungal controls, were obtained from the co-culture extracts. The known antibiotically active compound lateropyrone (6), the depsipeptides enniatins B (11), B1 (12) and A1 (13), and the lipopeptide fusaristatin A (14), that were present in axenic fungal controls and in co-culture extracts, were upregulated in the latter. The structures of the new compounds were elucidated by 1D and 2D NMR spectra as well as by HRESIMS data. The relative and absolute configuration of dihydrolateropyrone (5) was elucidated by TDDFT-ECD calculations.
536 _ _ |a 333 - Anti-infectives (POF3-333)
|0 G:(DE-HGF)POF3-333
|c POF3-333
|f POF III
|x 0
536 _ _ |a 511 - Computational Science and Mathematical Methods (POF3-511)
|0 G:(DE-HGF)POF3-511
|c POF3-511
|f POF III
|x 1
536 _ _ |a Forschergruppe Gohlke (hkf7_20170501)
|0 G:(DE-Juel1)hkf7_20170501
|c hkf7_20170501
|f Forschergruppe Gohlke
|x 2
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Ebrahim, Weaam
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Bonus, Michele
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Gohlke, Holger
|0 P:(DE-Juel1)172663
|b 3
700 1 _ |a Mándi, Attila
|0 0000-0002-7867-7084
|b 4
700 1 _ |a Kurtán, Tibor
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Hartmann, Rudolf
|0 P:(DE-Juel1)132001
|b 6
|u fzj
700 1 _ |a Kalscheuer, Rainer
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Lin, Wenhan
|0 0000-0002-4978-4083
|b 8
700 1 _ |a Liu, Zhen
|0 0000-0003-3314-7853
|b 9
|e Corresponding author
700 1 _ |a Proksch, Peter
|0 P:(DE-HGF)0
|b 10
|e Corresponding author
773 _ _ |a 10.1039/C8RA09067J
|g Vol. 9, no. 3, p. 1491 - 1500
|0 PERI:(DE-600)2623224-8
|n 3
|p 1491 - 1500
|t RSC Advances
|v 9
|y 2019
|x 2046-2069
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/859436/files/c8ra09067j.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://juser.fz-juelich.de/record/859436/files/c8ra09067j.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:859436
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)172663
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)132001
913 1 _ |a DE-HGF
|l Infektionsforschung
|1 G:(DE-HGF)POF3-330
|0 G:(DE-HGF)POF3-333
|2 G:(DE-HGF)POF3-300
|v Anti-infectives
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
913 1 _ |a DE-HGF
|b Key Technologies
|1 G:(DE-HGF)POF3-510
|0 G:(DE-HGF)POF3-511
|2 G:(DE-HGF)POF3-500
|v Computational Science and Mathematical Methods
|x 1
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|l Supercomputing & Big Data
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b RSC ADV : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC 3.0
|0 LIC:(DE-HGF)CCBYNC3
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)JSC-20090406
|k JSC
|l Jülich Supercomputing Center
|x 0
920 1 _ |0 I:(DE-Juel1)NIC-20090406
|k NIC
|l John von Neumann - Institut für Computing
|x 1
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|k ICS-6
|l Strukturbiochemie
|x 2
980 1 _ |a FullTexts
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)JSC-20090406
980 _ _ |a I:(DE-Juel1)NIC-20090406
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
981 _ _ |a I:(DE-Juel1)IBI-7-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21